1195 related articles for article (PubMed ID: 16537089)
21. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
22. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
23. What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
Abu-Rustum NR; Chi DS; Leitao M; Oke EA; Hensley ML; Alektiar KM; Barakat RR
Gynecol Oncol; 2008 Oct; 111(1):46-8. PubMed ID: 18657853
[TBL] [Abstract][Full Text] [Related]
24. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas.
Querleu D; Dargent D; Ansquer Y; Leblanc E; Narducci F
Cancer; 2000 Apr; 88(8):1883-91. PubMed ID: 10760766
[TBL] [Abstract][Full Text] [Related]
25. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
26. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
27. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
28. Significance of lymph node sampling in epithelial carcinoma of the ovary.
Carnino F; Fuda G; Ciccone G; Iskra L; Guercio E; Dadone D; Conte PF
Gynecol Oncol; 1997 Jun; 65(3):467-72. PubMed ID: 9190977
[TBL] [Abstract][Full Text] [Related]
29. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.
Cass I; Li AJ; Runowicz CD; Fields AL; Goldberg GL; Leuchter RS; Lagasse LD; Karlan BY
Gynecol Oncol; 2001 Jan; 80(1):56-61. PubMed ID: 11136570
[TBL] [Abstract][Full Text] [Related]
30. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
[TBL] [Abstract][Full Text] [Related]
31. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer.
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976
[TBL] [Abstract][Full Text] [Related]
32. Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Frigerio L; Candiani M; Savarese A; Giorda G; Lauria R; Tamberi S; Greggi S; Lorusso D
Gynecol Oncol; 2013 Jul; 130(1):38-42. PubMed ID: 23623833
[TBL] [Abstract][Full Text] [Related]
33. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
[TBL] [Abstract][Full Text] [Related]
34. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary.
Wolf JK; Mullen J; Eifel PJ; Burke TW; Levenback C; Gershenson DM
Gynecol Oncol; 1999 Apr; 73(1):35-41. PubMed ID: 10094877
[TBL] [Abstract][Full Text] [Related]
35. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
36. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
[TBL] [Abstract][Full Text] [Related]
37. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
38. Granulosa cell tumors of the ovary: prognostic factors and outcome.
Malmström H; Högberg T; Risberg B; Simonsen E
Gynecol Oncol; 1994 Jan; 52(1):50-5. PubMed ID: 8307501
[TBL] [Abstract][Full Text] [Related]
39. [Relevance of surgical lymph node staging for malignant ovarian germ cell tumors].
Charvolin JY; Querleu D
Contracept Fertil Sex; 1999 Jan; 27(1):51-5. PubMed ID: 10071448
[TBL] [Abstract][Full Text] [Related]
40. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
